Irreversible CYP3A Inhibition Accompanied by Plasma Protein–Binding Displacement: A Comparative Analysis in Subjects With Normal and Impaired Liver Function-Reference-Cited by-同舟云学术

Irreversible CYP3A Inhibition Accompanied by Plasma Protein–Binding Displacement: A Comparative Analysis in Subjects With Normal and Impaired Liver Function

Published:2008-11-19 Issue:3 Volume:85 Page:319-326
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Orlando R,De Martin S,Pegoraro P,Quintieri L,Palatini P

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Predicting Inhibitory Drug—Drug Interactions and Evaluating Drug Interaction Reports Using Inhibition Constants

2. Evaluation of inhibitory drug interactions during drug development: Genetic polymorphisms must be considered

3. Hepatic Cytochrome P450 Regulation in Disease States

4. METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION?

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges;Current Pharmacology Reports;2021-10-01

2. Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment;Alimentary Pharmacology & Therapeutics;2021-07-04

3. Physiologically‐Based Pharmacokinetic Modeling for Optimal Dosage Prediction of Quinine Coadministered With Ritonavir‐Boosted Lopinavir;Clinical Pharmacology & Therapeutics;2020-01-12

4. Macrolides, Azalides, and Ketolides;Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions;2018

5. The Impact of Liver Disease on Drug Metabolism;Surgical Procedures on the Cirrhotic Patient;2017